Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
MDT Stock News and Mentions of Medtronic plc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where Medtronic Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of Medtronic plc. (MDT).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the Medtronic stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of Medtronic plc. (MDT)
April 26, 2024 (17:15) / "Forbes" (by Expert Panel®)
Council Post: Challenges For Underrepresented Groups In Tech ( And How To Solve Them )
Challenges For Underrepresented Groups In Tech ( And How To Solve Them ) Forbes ...
In Article Trend: Somewhat-Bullish
April 26, 2024 (11:56) / "Canada Newswire" (by Medtronic plc)
Medtronic receives FDA approval for Inceptiv™ closed-loop spinal cord stimulator
DUBLIN, April 26, 2024 /CNW/ -- Medtronic plc ( NYSE:MDT ) , a global leader in healthcare technology, today announced that the U.S. Food and Drug Administration ( FDA ) has approved the Inceptiv™ closed-loop rechargeable spinal cord stimulator ( SCS ) for the treatment of chronic pain.
In Article Trend: Neutral
April 24, 2024 (22:47) / "Investing News Network" (by Investing News Network)
Investing in Cardiovascular MedTech Companies
Efforts to address the core risk factors associated with cardiovascular diseases are coinciding with recent innovations in medical technology, which have been critical in not only preventing and managing them but also increasing the survival rate.
In Article Trend: Bullish
April 24, 2024 (14:15) / "Benzinga" (by Globe Newswire)
Electrotherapy System Market size worth $ 1587.04 Billion, Globally, by 2031 at 4.39% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 24, 2024 ( GLOBE NEWSWIRE ) -- The Global Electrotherapy System Market is projected to grow at a CAGR of 4.39% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 24, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic PLC ( MDT ) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Article Trend: Somewhat-Bullish
April 24, 2024 (12:00) / "PR Newswire" (by Valcare Medical)
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
TAMPA, Fla., April 24, 2024 /PRNewswire/ -- Valcare Medical, Inc., a leading innovator in transcatheter-based mitral solutions, today announced a comprehensive corporate restructure aimed at accelerating the company's plans to initiate the AMEND clinical studies following the recent company ...
In Article Trend: Bullish
April 23, 2024 (23:13) / "Investing News Network" (by Investing News Network)
March Quarterly Appendix 4C
Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds ( 66% ) would choose a shorter, healthier ...
In Article Trend: Somewhat-Bullish
April 23, 2024 (17:00) / "Benzinga" (by Globe Newswire)
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa Flicek as Chief Information Officer
EAGAN, Minn., April 23, 2024 ( GLOBE NEWSWIRE ) -- Blue Cross and Blue Shield of Minnesota ( Blue Cross ) today announced the addition of two executive hires within its government markets and operations divisions.
In Article Trend: Somewhat-Bullish
April 23, 2024 (13:36) / "CNBC" (by Rachel Curry)
Less burnout for doctors, better clinical trials, among the benefits of AI in health care
Artificial intelligence has traditionally been used to make healthcare safer and better. Now generative AI is making efficency a priority.
In Article Trend: Neutral
April 22, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Laps the Stock Market: Here's Why
Medtronic (MDT) reachead $80.57 at the closing of the latest trading day, reflecting a +1.37% change compared to its last close.
In Article Trend: Neutral
April 19, 2024 (22:12) / "PR Newswire"
Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... - PR Newswire
Endoscopy Devices Market size is set to grow by USD 14.24 billion from 2024-2028, advances in endoscopy ... PR ...
In Article Trend: Somewhat-Bullish
April 19, 2024 (16:44) / "Investing News Network" (by Investing News Network)
Medtronic: Americans Favor Quality Over Quantity in Pursuit of Longevity
Americans overwhelmingly say that when they think about longevity, it's more than just living longer - it's about living their healthiest, best lives. While most want to live to 90-well past the average U.S. life expectancy of 77.5 years-nearly two-thirds ( 66% ) would choose a shorter, healthier ...
In Article Trend: Somewhat-Bullish
April 19, 2024 (13:24) / "Investing News Network" (by Investing News Network)
Cardiex: Biomarker Technologies, Digital Solutions to Address the World's Largest Health Disorders
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues Americans overwhelmingly say that when they think about longevity, it's more than just living longer-it's about living ...
In Article Trend: Somewhat-Bullish
April 18, 2024 (17:00) / "Benzinga" (by Benzinga Insights)
Looking Into Medtronic's Recent Short Interest - Medtronic ( NYSE:MDT )
Medtronic's MDT short percent of float has risen 8.05% since its last report. The company recently reported that it has 12.43 million shares sold short, which is 0.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.18 days to cover their ...
In Article Trend: Somewhat-Bullish
April 18, 2024 (15:09) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) due to the strength of its Neurosurgery and Cardiovascular portfolios.
In Article Trend: Somewhat-Bullish
April 18, 2024 (13:05) / "Motley Fool" (by David Jagielski)
Medtronic Stock: Buy, Sell, or Hold?
Can this struggling healthcare specialist turn things around?
In Article Trend: Bullish
April 17, 2024 (14:30) / "Benzinga" (by Globe Newswire)
Blood Collection Market size worth $ 14.76 Billion, Globally, by 2031 at 5.10% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 17, 2024 ( GLOBE NEWSWIRE ) -- The Global Blood Collection Market is projected to grow at a CAGR of 5.10% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 17, 2024 (10:00) / "Zacks Commentary" (by Zacks Investment Research)
The Zacks Analyst Blog Highlights Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic
Mastercard, Netflix, Coca-Cola, Berkshire Hathaway and Medtronic are included in this Analyst Blog.
In Article Trend: Somewhat-Bullish
April 16, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Stock Sinks As Market Gains: What You Should Know
Medtronic (MDT) concluded the recent trading session at $79.35, signifying a -1.1% move from its prior day's close.
In Article Trend: Neutral
April 16, 2024 (13:00) / "PR Newswire"
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO - PR Newswire
Ascential Medical & Life Sciences Appoints Anupam Girdhar as Divisional CEO PR ...
In Article Trend: Somewhat-Bullish
April 16, 2024 (08:55) / "Motley Fool" (by Adria Cimino)
2 Artificial Intelligence ( AI ) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners.
In Article Trend: Bullish
April 16, 2024 (00:34) / "Forbes" (by John Navin)
These 4 NYSE Stocks Just Broke Below Previous Price Support
When buyers fail to show up at the price where they previously paid, it's a sign of weakness for a stock. You don't need a thorough understanding of technical analysis to appreciate this. It's not that much different than a goods store marking down merchandise since it's not being purchased at ...
In Article Trend: Neutral
April 15, 2024 (18:42) / "Benzinga" (by Vandana Singh)
Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA Why Is Medical Device Manufacture Integer Stock Gaining Today? - Integer Holdings ( NYSE:ITGR )
BofA Securities upgraded Integer Holdings Corporation ITGR, citing the anticipated growth in pulsed field ablation ( PFA ) for treating atrial fibrillation. Integer is one of the largest medical device outsourcing manufacturers, serving the cardiac rhythm management, neuromodulation, ...
In Article Trend: Somewhat-Bullish
April 15, 2024 (14:15) / "Benzinga" (by Globe Newswire)
Wearable Injectors Market size worth $ 21.48 Billion, Globally, by 2031 at 15.30% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 15, 2024 ( GLOBE NEWSWIRE ) -- The Global Wearable Injectors Market is projected to grow at a CAGR of 15.30% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Somewhat-Bullish
April 13, 2024 (11:24) / "CNBC" (by Kenneth Squire)
Third Point, Saddle Point win board seats at Advance Auto Parts. A plan to improve margins may unfold
The two activists recently picked up three board seats at the auto parts retailer.
In Article Trend: Neutral
April 12, 2024 (13:00) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic PLC ( MDT ) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Medtronic (MDT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
In Article Trend: Somewhat-Bullish
April 11, 2024 (13:31) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Sphere-360 PFA Study Outcome Favorable
Medtronic's (MDT) Sphere-360 catheter is designed to simplify the atrial fibrillation process while increasing efficiency and giving long-lasting lesions.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:45) / "Benzinga" (by Zacks)
Boston Scientific ( BSX ) Faces Rising Costs, Competition - Boston Scientific ( NYSE:BSX ) , Cardinal Health ( NYSE:CAH )
Boston Scientific Corporation BSX has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in the large medical device market also pose a tough challenge for Boston Scientific. The stock carries a Zacks Rank #4 ( Sell ) currently.
In Article Trend: Neutral
April 11, 2024 (10:15) / "Motley Fool" (by Prosper Junior Bakiny)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
These companies provide stability, reliability, and passive income.
In Article Trend: Somewhat-Bullish
April 11, 2024 (10:05) / "Motley Fool" (by Adria Cimino)
Here Are My Top Artificial Intelligence ( AI ) Stocks to Buy Now
These three players offer you a great entry point right now.
In Article Trend: Bullish
April 10, 2024 (23:40) / "Investing News Network" (by Investing News Network)
CLEO Appoints CRO to Manage U.S. Ovarian Cancer Clinical Trials
AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy
In Article Trend: Bullish
April 10, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Falls More Steeply Than Broader Market: What Investors Need to Know
Medtronic (MDT) reachead $82.33 at the closing of the latest trading day, reflecting a -1.75% change compared to its last close.
In Article Trend: Neutral
April 10, 2024 (13:39) / "Business Insider" (by Avi Kapoor)
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic ( NYSE:MDT ) . "I like what they're doing in AI. You've got a good one with a good yield," he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for ...
In Article Trend: Somewhat-Bullish
April 10, 2024 (13:30) / "Zacks Commentary" (by Zacks Equity Research)
Boston Scientific ( BSX ) Faces Rising Costs, Competition
With Boston Scientific (BSX) recording 40% of its sales from the international market, it remains highly exposed to currency fluctuations.
In Article Trend: Neutral
April 10, 2024 (13:18) / "Benzinga" (by Avi Kapoor)
Jim Cramer Says WESCO International Is A Buy, Recommends Buying This Stock Under $20 - Cleveland-Cliffs ( NYSE:CLF ) , Medtronic ( NYSE:MDT )
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended buying Medtronic MDT. "I like what they're doing in AI. You've got a good one with a good yield," he noted. On March 27, the FDA approved Medtronic's Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic ...
In Article Trend: Somewhat-Bullish
April 9, 2024 (00:15) / "Benzinga" (by Globe Newswire)
ThoughtSpot Named Google Cloud Technology Partner of the Year for Data - Business Intelligence
MOUNTAIN VIEW, Calif., April 08, 2024 ( GLOBE NEWSWIRE ) -- ThoughtSpot, the AI-Powered Analytics company, today announced it has been named the 2024 Google Cloud Technology Partner of the Year Award for Data - Business Intelligence.
In Article Trend: Somewhat-Bullish
April 8, 2024 (14:00) / "Benzinga" (by Globe Newswire)
mHealth Market size worth $ 122.50 Billion, Globally, by 2031 at 10.54% CAGR - Report By Verified Market Research®
Jersey City, New Jersey, April 08, 2024 ( GLOBE NEWSWIRE ) -- The Global mHealth Solutions Market is projected to grow at a CAGR of 10.54% from 2024 to 2031, according to a new report published by Verified Market Research®.
In Article Trend: Bullish
April 8, 2024 (12:40) / "Investing News Network" (by Investing News Network)
The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
The Medtronic Sphere-360 Pulse Field Ablation catheter, a new paradigm in single-shot ablation, demonstrates ... Investing News Network ...
In Article Trend: Somewhat-Bullish
April 8, 2024 (12:00) / "Canada Newswire"
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation ... - Canada NewsWire
The Medtronic Sphere-360™ Pulse Field Ablation ( PFA ) catheter, a new paradigm in single-shot ablation ... Canada ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (13:45) / "PR Newswire" (by Medtronic plc)
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic ... PR ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (13:45) / "Canada Newswire" (by Medtronic plc)
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic ... Canada ...
In Article Trend: Somewhat-Bullish
April 7, 2024 (12:00) / "PR Newswire" (by Medtronic plc)
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease
In Article Trend: Somewhat-Bullish
April 7, 2024 (12:00) / "Canada Newswire" (by Medtronic plc)
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities for awareness amongst women at risk for cardiovascular disease
In Article Trend: Somewhat-Bullish
April 4, 2024 (21:50) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Medtronic (MDT) stood at $83.92, denoting a -1.27% change from the preceding trading day.
In Article Trend: Neutral
April 4, 2024 (17:29) / "Benzinga" (by Zacks)
Globus Medical ( GMED ) Gains From New Launches Amid Macro Issues - DaVita ( NYSE:DVA ) , Cardinal Health ( NYSE:CAH )
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding in the overseas markets through the expansion of direct and distributor sales force.
In Article Trend: Somewhat-Bullish
April 4, 2024 (12:41) / "Zacks Commentary" (by Zacks Equity Research)
Globus Medical ( GMED ) Gains From New Launches Amid Macro Issues
Globus Medical (GMED) witnesses notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings.
In Article Trend: Somewhat-Bullish
April 3, 2024 (15:30) / "Benzinga" (by Globe Newswire)
Transformative Growth Expected In The Global Medical Equipment Market: Market Size To Reach $1,077 Billion By 2028 As Per The Business Research Company's Medical Equipment Global Market Report 2024
LONDON, April 03, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Medical Equipment Global Market Report 2024, the medical equipment market has witnessed robust growth in recent years, with the market size expected to reach $775.42 billion in 2024, reflecting a compound annual ...
In Article Trend: Somewhat-Bullish
April 3, 2024 (10:20) / "Zacks Commentary" (by Zacks Equity Research)
Should You Invest in the iShares U.S. Medical Devices ETF ( IHI ) ?
Sector ETF report for IHI ...
In Article Trend: Somewhat-Bullish
April 2, 2024 (12:30) / "Benzinga" (by Globe Newswire)
Electroceuticals/Bioelectric Medicine Market is Expected to Reach $33.6 billion | MarketsandMarkets™
Chicago, April 02, 2024 ( GLOBE NEWSWIRE ) -- Electroceuticals/Bioelectric Medicine market in terms of revenue was estimated to be worth $23.9 billion in 2024 and is poised to reach $33.6 billion by 2029, growing at a CAGR of 7.0% from 2024 to 2029 according to a latest report published by ...
In Article Trend: Somewhat-Bullish
April 2, 2024 (05:54) / "GlobeNewswire" (by BioPorto A/S)
BioPorto appoints Peter Mørch Eriksen as permanent Group Chief Executive Officer
April 2, 2024Announcement no. ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (20:05) / "Benzinga" (by Globe Newswire)
Acutus Medical Reports Fourth Quarter and Full Year 2023 Financial Results - Acutus Medical ( NASDAQ:AFIB )
CARLSBAD, Calif., April 01, 2024 ( GLOBE NEWSWIRE ) -- Acutus Medical, Inc. ( "Acutus" or the "Company" ) AFIB today reported results for the fourth quarter and full year ended December 31,2023.
In Article Trend: Somewhat-Bullish
April 1, 2024 (14:41) / "Zacks Commentary" (by Zacks Equity Research)
Tandem Diabetes ( TNDM ) Gains From Innovation Amid Macro Issues
Tandem Diabetes (TNDM) seeks to grow its business through the acquisition of products or technologies and investments in businesses.
In Article Trend: Somewhat-Bullish
April 1, 2024 (12:15) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) Newest Evolut TAVR System Gets FDA Approval
Medtronic (MDT) announces the FDA approval of the newest-generation Evolut TAVR system for the treatment of symptomatic severe aortic stenosis.
In Article Trend: Somewhat-Bullish
March 31, 2024 (18:17) / "Motley Fool" (by Cory Renauer)
Better Dividend Stock to Buy Now: Medtronic vs. Walgreens Boots Alliance
Which dividend-paying healthcare stock is better positioned to produce a rapidly growing payout?
In Article Trend: Neutral
March 31, 2024 (11:45) / "Motley Fool" (by Prosper Junior Bakiny)
2 Healthcare Artificial Intelligence ( AI ) Stocks That Could Be Smart Investment Bets
There are many ways to cash in on the rise of AI.
In Article Trend: Somewhat-Bullish
March 31, 2024 (10:20) / "Motley Fool" (by Selena Maranjian)
The Smartest Dividend Stocks to Buy With $400 Right Now
Dividend-payers aren't just for your grandparents -- they actually outperform non-payers, according to one study.
In Article Trend: Somewhat-Bullish
March 30, 2024 (09:19) / "Motley Fool" (by Cory Renauer)
3 Reliable Dividend Growth Stocks With Yields Above 3% That You Can Buy Now and Hold for at Least a Decade
These advantaged businesses have what it takes to keep raising their payouts.
In Article Trend: Somewhat-Bullish
March 29, 2024 (21:41) / "GlobeNewswire" (by Titan Medical Inc.)
Titan Medical Reports Fiscal Year 2023 Results
TORONTO, Ontario, March 29, 2024 ( GLOBE NEWSWIRE ) -- Titan Medical Inc. ( "Titan" or the "Company" ) ( TSX: TMD. OTC: TMDIF ) , today reported financial results for the fiscal year ended December 31, 2023.
In Article Trend: Somewhat-Bullish
March 28, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
National Vision ( EYE ) Down 4.1% Since Last Earnings Report: Can It Rebound?
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Neutral
March 28, 2024 (14:02) / "Zacks Commentary" (by Zacks Equity Research)
Shockwave Medical ( SWAV ) Up on Potential Acquisition Rumors
Shockwave Medical's (SWAV) shares gain as rumors about its potential acquisition by an industry giant get media attention.
In Article Trend: Somewhat-Bullish
March 28, 2024 (05:30) / "Barrons" (by Andy Serwer)
Ben & Jerry's Long, Strange Trip to a Multibillion-Dollar Valuation
In a game of word association, "ice cream" and "complexity" might not leap to mind, but these days they should. You probably saw last week that global goliath Unilever said it was looking to jettison its ice cream business, which includes America's grooviest company, Ben & Jerry's.
In Article Trend: Neutral
March 27, 2024 (20:23) / "Benzinga" (by Vandana Singh)
Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst - Boston Scientific ( NYSE:BSX ) , Johnson & Johnson ( NYSE:JNJ ) , Medtronic ( NYSE:MDT ) , Shockwave Medical ( NASDAQ:SWAV )
Tuesday, Shockwave Medical Inc SWAV shares traded higher following a Wall Street Journal report suggesting Johnson & Johnson JNJ is reportedly in talks to acquire the company. Shockwave Medical is a cardiovascular medical device.
In Article Trend: Somewhat-Bullish
March 27, 2024 (20:17) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
NEW HOPE, Pa., March 27, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (18:14) / "Benzinga" (by Vandana Singh)
Why Is Medtronic Stock Trading Higher On Wednesday? - Medtronic ( NYSE:MDT )
Wednesday, the FDA approved Medtronic plc's MDT Evolut FX+ transcatheter aortic valve replacement ( TAVR ) system for symptomatic severe aortic stenosis. The latest Evolut FX+ TAVR system maintains the valve performance benefits of the legacy Evolut TAVR platform and is designed to facilitate ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (16:23) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Zimmer Biomet ( ZBH ) Stock Now
Investors are optimistic about Zimmer Biomet (ZBH), led by expansion in the knee business and recovery across the business.
In Article Trend: Somewhat-Bullish
March 27, 2024 (12:45) / "Investing News Network" (by Investing News Network)
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Investing News Network ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (12:00) / "Canada Newswire"
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... - Canada NewsWire
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe ... Canada ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (08:50) / "Motley Fool" (by Adria Cimino)
3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000
Each of these three companies are entering a new era of growth.
In Article Trend: Somewhat-Bullish
March 26, 2024 (14:00) / "Motley Fool" (by Adria Cimino)
Prediction: Healthcare Stocks Could Become the Biggest Winners of the Artificial Intelligence ( AI ) Boom and Here's Why.
A key player in AI is very optimistic about the technology's potential in healthcare.
In Article Trend: Bullish
March 26, 2024 (12:00) / "GlobeNewswire" (by Inc.)
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors
NEW HOPE, Pa., March 26, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the appointment of David ...
In Article Trend: Somewhat-Bullish
March 25, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Abbott ( ABT ) Expands in Canada With First Eterna SCS Use
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
In Article Trend: Somewhat-Bullish
March 25, 2024 (06:00) / "Business Insider" (by markets.businessinsider.com)
Tricares Announces the Appointment of Ahmed Elmouelhi as President & Chief Executive Officer
Paris, France and Munich, Germany, March 25, 2024 - TRiCares SAS ( "TRiCares" ) a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today is pleased to announce the appointment of Ahmed Elmouelhi as President & Chief Executive Officer ( CEO ) .
In Article Trend: Somewhat-Bullish
March 24, 2024 (23:47) / "Investing News Network" (by Investing News Network)
Peer-Review Further Supports CLEO's Ovarian Cancer Detection Technology
Medtronic moves for patent infringement litigation to resume Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.
In Article Trend: Somewhat-Bearish
March 23, 2024 (07:46) / "Motley Fool" (by Adria Cimino)
Artificial Intelligence ( AI ) in Healthcare: 2 Top Stock Picks
These particular healthcare stocks are dirt cheap now considering their AI potential.
In Article Trend: Bullish
March 22, 2024 (16:24) / "Zacks Commentary" (by Zacks Equity Research)
Tandem Diabetes ( TNDM ) Gains From Innovation Amid Competition
Tandem Diabetes (TNDM), in 2024, intends to advance its AID algorithm and expand its indications to include people living with Type 2 diabetes.
In Article Trend: Somewhat-Bullish
March 21, 2024 (18:51) / "Canada Newswire" (by Medtronic plc)
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
DUBLIN, March 21, 2024 /CNW/ -- Medtronic ( NYSE:MDT ) , the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board ( PTAB ) of the U.S.
In Article Trend: Neutral
March 21, 2024 (17:15) / "Benzinga" (by Benzinga Insights)
Looking Into Medtronic's Recent Short Interest - Medtronic ( NYSE:MDT )
Medtronic's MDT short percent of float has fallen 9.76% since its last report. The company recently reported that it has 9.81 million shares sold short, which is 0.74% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.77 days to cover their ...
In Article Trend: Somewhat-Bullish
March 21, 2024 (15:30) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic ( MDT ) Down 2.2% Since Last Earnings Report: Can It Rebound?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
March 21, 2024 (13:45) / "Motley Fool" (by Prosper Junior Bakiny)
Bull Market and Beyond: 2 Stocks to Buy and Hold Forever
These stocks have been providing excellent returns for a long time.
In Article Trend: Bullish
March 21, 2024 (12:45) / "Motley Fool" (by Prosper Junior Bakiny)
1 Magnificent Growth Stock to Buy and Hold
Investing in this company 10 years ago would have produced excellent returns, but it's not too late -- far from it.
In Article Trend: Somewhat-Bullish
March 20, 2024 (21:45) / "CNN" (by Jacqueline Howard)
People with darker skin are 32% more likely to have pulse oximeter readings overestimate oxygen levels, report says
Scientists have long known that pulse oximeters are less accurate when used for people with dark skin tones - and now, a new report offers some insight into just how much more inaccurate these fingertip clamps can be.
In Article Trend: Neutral
March 20, 2024 (03:03) / "Benzinga" (by Benzinga Neuro)
Jim Cramer Reveals Nvidia's Non-Tech Partners That Can Be Potential Market Winner: 'Best Opportunities' - Getty Images Holdings ( NYSE:GETY ) , GE HealthCare Techs ( NASDAQ:GEHC )
CNBC host Jim Cramer has spotlighted several lesser-known partners of NVIDIA Corp NVDA that could potentially benefit from the company's advanced artificial intelligence ( AI ) technology.
In Article Trend: Somewhat-Bullish
March 19, 2024 (15:40) / "Benzinga" (by Globe Newswire)
Cartilage Repair Market Anticipates Rapid Growth, Projected To Reach $2.3 Billion In 2028 As Per The Business Research Company's Cartilage Repair Global Market Report 2024
LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The Business Research Company's Cartilage Repair Market Global Report 2024 forecasts significant growth, with the cartilage repair market size expected to rise from $1.24 billion in 2023 to $1.42 billion in 2024, demonstrating a compound annual growth ...
In Article Trend: Somewhat-Bullish
March 19, 2024 (15:40) / "Benzinga" (by Globe Newswire)
Cardiovascular Implants Market Poised For Strong Growth, Reaching $34.5 Billion In 2028: Latest Report Unveils Insights As Per The Business Research Company's Cardiovascular Implants Global Market Report 2024
LONDON, March 19, 2024 ( GLOBE NEWSWIRE ) -- The global cardiovascular implants market is experiencing robust growth, as highlighted in the newest report "Cardiovascular Implants Market Global Report 2024", by The Business Research Company.
In Article Trend: Bullish
March 18, 2024 (12:23) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Buy Insulet ( PODD ) Stock Right Now
Investors remain confident in the Insulet (PODD) stock due to the huge success of Omnipod 5.
In Article Trend: Somewhat-Bullish
March 18, 2024 (07:30) / "Motley Fool" (by Adria Cimino)
Here Are My Top Artificial Intelligence ( AI ) Stocks to Buy in March
AI already is boosting revenue at these companies...
In Article Trend: Somewhat-Bullish
March 17, 2024 (08:45) / "Motley Fool" (by Chuck Saletta)
3 Companies With Strong Irish Operations
St. Patrick's Day provides the perfect opportunity to raise a toast to some of the great companies that operate from the Emerald Isle.
In Article Trend: Somewhat-Bullish
March 15, 2024 (17:17) / "Barrons" (by Teresa Rivas)
Think Stock Prices Are Too High? 5 Ways to Prepare for a Drop.
Think the Market Is Too Hot? 5 Ways to Get Defensive Now. ...
In Article Trend: Somewhat-Bullish
March 15, 2024 (13:32) / "PR Newswire" (by Fortune Media (USA) Corporation)
Fortune Launches First Innovation Forum in Hong Kong March 27- 28
All new annual conference on critical issues in tech, finance, talent and energy, with a spotlight on Asia and convening industry leaders and investors from some of the world's most dynamic companies Over 60 speakers, including top executives from Google, Amazon, Intel, Nike, Rakuten, Walmart, ...
In Article Trend: Bullish
March 14, 2024 (05:49) / "Investing News Network" (by Investing News Network)
Funding Commitment Agreement Update
Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two oral presentations were given at the Cardiovascular Research Technologies ( ...
In Article Trend: Neutral
March 13, 2024 (16:04) / "Investors Business Daily" (by ALLISON GATLIN)
IBD Stock Of The Day Lingers In Buy Zone As Diabetes Play Eyes Obesity
Dexcom ( DXCM ) is Wednesday's IBD Stock Of The Day. Dexcom stock is lingering in a buy zone, bolstered by U.S. clearance of a new body-worn glucose monitor. The company developed Stelo, its newest continuous glucose monitor, for the roughly 25 million people in the U.S. with type 2 diabetes ...
In Article Trend: Neutral
March 13, 2024 (16:01) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Globus Medical ( GMED ) Stock Now
Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
In Article Trend: Somewhat-Bullish
March 12, 2024 (12:03) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Retain Medtronic ( MDT ) Stock for Now
Investors continue to be optimistic about Medtronic (MDT) on the strength of the Neurosurgery and Cardiovascular and Neurosurgery portfolios.
In Article Trend: Somewhat-Bullish
March 11, 2024 (13:17) / "Zacks Commentary" (by Zacks Equity Research)
Medtronic's ( MDT ) MiniMed 780G System Study Data Favorable
Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
In Article Trend: Somewhat-Bullish
March 11, 2024 (08:16) / "PR Newswire"
Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... - PR Newswire
Surgical Sutures Market size is set to grow by USD 1102.57 mn from 2023-2027. Increase in volume of surgeries boost ... PR ...
In Article Trend: Neutral
March 9, 2024 (11:35) / "Investing News Network" (by Investing News Network)
New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets for diabetes management
New real-world data shows MiniMed 780G system sustains strong global performance, exceeding international targets ... Investing News Network ...
In Article Trend: Somewhat-Bullish
March 9, 2024 (10:40) / "PR Newswire"
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international ... - PR Newswire
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international ... PR ...
In Article Trend: Somewhat-Bullish
March 8, 2024 (14:15) / "Motley Fool" (by David Jagielski)
2 Medical Device Stocks to Buy Hand Over Fist in March
Don't let their modest gains over the past year mislead you. these stocks can make for great long-term investments.
In Article Trend: Bullish
March 7, 2024 (19:57) / "Benzinga" (by Vandana Singh)
Medtronic Recalls Neurosurgery Catheter Tubing, FDA Identifies As Serious Recall - Medtronic ( NYSE:MDT )
Medtronic Plc's MDT Neurosurgery unit on Thursday said it is recalling the Duet External Drainage and Monitoring System ( EDMS ) catheter tubing due to a potential for the catheter disconnection from the patient line stopcock connectors.
In Article Trend: Somewhat-Bearish
March 7, 2024 (13:00) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed to Participate in Upcoming Investor Conferences
NEW HOPE, Pa., March 07, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management ...
In Article Trend: Neutral
March 6, 2024 (22:48) / "Forbes" (by Katie Jennings)
InnovationRx: Biopharma VCs Placed Fewer But Surer Bets In 2023
Biopharma venture capitalists placed fewer bets in 2023, per PitchBook Forbes ...
In Article Trend: Neutral
March 6, 2024 (13:37) / "GlobeNewswire" (by Orchestra BioMed Holdings)
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients
NEW HOPE, Pa., March 06, 2024 ( GLOBE NEWSWIRE ) -- Orchestra BioMed Holdings, Inc. ( Nasdaq: OBIO, "Orchestra BioMed" or the "Company" ) , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of new ...
In Article Trend: Neutral
March 5, 2024 (11:37) / "Motley Fool" (by Cory Renauer)
3 High-Yield S&P 500 Dividend Stocks Down More Than 28% to Buy Now and Hold at Least a Decade
Each of these companies has decades-long consecutive annual dividend-raising streaks.
In Article Trend: Somewhat-Bullish
March 4, 2024 (13:05) / "Benzinga" (by Globe Newswire)
Global Urinary Incontinence Treatment Devices Market Size is Estimated to Reach USD 6.02 billion by 2030, Growing at a CAGR of 6.58%: Straits Research
New York, United States, March 04, 2024 ( GLOBE NEWSWIRE ) -- A medical disease called urinary incontinence causes uncontrollable urine loss. Medical devices are used to treat chronic urine incontinence and to grow and strengthen the pelvic floor muscles.
In Article Trend: Neutral
February 29, 2024 (16:30) / "Benzinga" (by Globe Newswire)
Endoscopic Camera Market Size Is Expected To Grow At A Rate Of More Than 9% Through 2024-2028 As Per The Business Research Company's Endoscopic Camera Global Market Report 2024
LONDON, Feb. 29, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Endoscopic Camera Global Market Report 2024, the endoscopic camera market has witnessed robust growth in recent years, with significant advancements in minimally invasive surgery, medical training, and patient ...
In Article Trend: Somewhat-Bullish
February 28, 2024 (14:12) / "Zacks Commentary" (by Zacks Equity Research)
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic
Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
Fate Therapeutics, Inc. (FATE)
Enveric Biosciences, Inc. (ENVB)
Catalent, Inc. (CTLT)
ObsEva SA (OBSV)
Royalty Pharma plc (RPRX)
IDEXX Laboratories, Inc. (IDXX)
Cardinal Health, Inc. (CAH)
Altamira Therapeutics Ltd. (CYTO)
Bright Health Group, Inc. (BHG)
Charles River Laboratories International, Inc. (CRL)
This website uses cookies to ensure you get the best experience on our website